Latanoprost/Timolol Biogaran (Timolol Maleate, Latanoprost)

Latanoprost is a prostaglandin F2α analog that binds to FP receptors in the ciliary body, enhancing uveoscleral outflow of aqueous humor. This increased outflow lowers intraocular pressure, contributing to glaucoma control.

Timolol is a non‑selective beta‑adrenergic antagonist that blocks beta‑receptors in the ciliary epithelium, reducing the production of aqueous humor. The decrease in fluid formation further lowers intraocular pressure.

The dosing regimen is set by the prescribing clinician. Typically, one drop is instilled in each affected eye once daily, often in the evening, but exact instructions must follow the prescriber’s order.

Safety data are limited and the product is classified as pregnancy category unknown. It should be used during pregnancy or lactation only when the potential benefit justifies the potential risk and under close medical supervision.

Enquiries are submitted via the product page on gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

The main alternative is using either a prostaglandin analog or a beta‑blocker alone. The combination offers dual mechanisms in a single bottle, often achieving greater intraocular pressure reduction than monotherapy and simplifying the treatment regimen for patients.

Store the eye‑drop bottles at room temperature, below 25 °C, in the original packaging. Protect from light and moisture, and keep the cap tightly closed to maintain sterility and product integrity.

The solution is applied topically to the conjunctival sac. After washing hands, tilt the head back, pull down the lower eyelid, instill one drop into the eye, then close the eye gently for a few minutes, avoiding contact between the bottle tip and the eye.

Serious adverse events include severe allergic reactions, bronchospasm in asthmatic patients, marked bradycardia, hypotension, and corneal edema. Patients should seek immediate medical attention if they experience difficulty breathing, rapid heartbeat, vision changes, or eye pain.